Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Rev. méd. Chile ; 136(7): 921-929, jul. 2008. tab
Article in Spanish | LILACS | ID: lil-496016

ABSTRACT

Gastrointestinal stromal tumors (GIS) are a heterogeneous group of tumors that express CD 117 molecule in their sur face. They may behave as benign tumors or be highly aggressive. A better survival of patients with these tumors has been achieved using the new molecular therapies such as imatinib mesylate, sunitinib and others. This review analyzes the prognostic factors of these tumors, their clinical features and the criteria for malignant behavior. The value of therapeutic alternatives such as radiotherapy chemotherapy and the new molecular therapies are also discussed.


Subject(s)
Humans , Gastrointestinal Stromal Tumors/therapy , Antineoplastic Agents/therapeutic use , Gastrointestinal Stromal Tumors/complications , Gastrointestinal Stromal Tumors/diagnosis , Indoles , Piperazines/therapeutic use , Protein Kinase Inhibitors/therapeutic use , Protein-Tyrosine Kinases/therapeutic use , Proto-Oncogene Proteins c-kit/therapeutic use , Pyrimidines/therapeutic use , Pyrroles
SELECTION OF CITATIONS
SEARCH DETAIL